07.30.20

Methotrexate Treat-and-Extend Tested for Vitreoretinopathy

Source: Medscape

A treat-and-extend regimen of methotrexate can be used to successfully treat proliferative vitreoretinopathy, according to a series of 50 eyes in which 96% of retinas were successfully reattached, Medscape reported.

“I’m really a believer in it, based on my own personal experience,” said Scott Walter, MD, from Retina Consultants in Hartford, Connecticut.

Proliferative vitreoretinopathy occurs when scars form after a retinal detachment repair or a traumatic injury. When the scar tissue contracts, it pulls on the retina and causes it to detach.

Read the full article.

Related Content

04.13.20

Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections
Source: The New York Eye and Ear Infirmary of Mount Sinai

04.01.20

COVID-19: Reports From US Hot Zones
Source: Broadcasted - Tuesday, March 31st at 9PM ET

04.21.20

Forecasting the New Normal: Experts Across Eye Care Discuss COVID-19’s Impact
Source: Broadcasted - Tuesday, April 21th at 3PM ET